Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461545) titled 'Apixaban for Prevention of Portal Vein Thrombosis After Laparoscopic Splenectomy : One-Year and Long-Term Follow-Up Study' on March 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
Cirrhosis
Splenectomy
Venous Thrombosis
Hypertension, Portal
Intervention:
Drug: Apixaban 2.5 MG
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 4, 2025
Target Sample Size: 40
Countries of Recruitment:
China
To know mor...